Publication of offer document

Publication of offer document On 26 June 2003, Fisher Scientific International Inc. ("Fisher") announced a recommended cash offer (the "Offer") to purchase all of the outstanding shares and all of the outstanding warrants issued under the 1999 warrant program of Perbio Science AB (publ) ("Perbio"). The Offer is made through FSII Sweden Holdings AB ("Fisher Sweden") a wholly owned Swedish subsidiary of Fisher. An offer document detailing the Offer has been filed with Finansinspektionen (the Swedish Financial Supervisory Authority) and will be available as of 10 July 2003 at Nordea Securities, Engelbrektsplan 1 in Stockholm, on Nordea's website, www.nordea.se, as well as at FSII Sweden Holdings AB, c/o Advokatfirman Hammarskiöld & Co, Norra Bankogränd 2 in Stockholm. The offer document, an acceptance form and a pre-paid envelope are submitted to those shareholders who have their holdings registered in their own names on the record date 7 July 2003. The offer document can also be ordered free of charge from Nordea Securities at telephone +46 8 678 0440. The Offer in brief · Fisher Sweden offers SEK 142.50 in cash for each Perbio share. · Fisher Sweden offers SEK 93.50 in cash for each outstanding warrant issued under the 1999 warrant program. · No commission will be charged. · The acceptance period commences on 10 July 2003 and ends on 14 August 2003. · Cash settlement is expected to occur on or around 28 August 2003 if it is announced, no later than 21 August 2003, that the conditions to the Offer have been satisfied or that the Offer otherwise will be completed. · The Perbio shares will be acquired with all rights attached thereto including the right to receive and retain all dividends or other distributions declared or payable on or after the date of the announcement of the Offer. Recommendation by the Board of Directors of Perbio The Board of Directors of Perbio unanimously recommends that the shareholders and holders of warrants issued under the 1999 program in Perbio accept the Offer. The Board of Directors' recommendation is supported by a fairness opinion, from a financial point of view, delivered to the Board of Directors of Perbio by its financial adviser Deutsche Bank AG London. In providing its advice to Perbio's Board of Directors, Deutsche Bank has taken into account, among other things, commercial assessments of Perbio's Board of Directors. Stockholm, 9 July 2003 FSII Sweden Holdings AB For further information regarding the tender process, please contact: Nordea Securities Telephone number: +46 8 678 0440 For other information, please contact: Carolyn Miller, Director of Investor Relations Fisher Scientific International Inc. Telephone number: +1 603 929 2381 This press release may not be released, published or distributed, directly or indirectly, in or into the United States of America, Australia, Japan, Canada, New Zealand or South Africa. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/07/09/20030709BIT00130/wkr0001.doc http://www.waymaker.net/bitonline/2003/07/09/20030709BIT00130/wkr0002.pdf